1. Home
  2. BILL vs LIVN Comparison

BILL vs LIVN Comparison

Compare BILL & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BILL Holdings Inc.

BILL

BILL Holdings Inc.

HOLD

Current Price

$43.61

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$78.17

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BILL
LIVN
Founded
2006
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.5B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
BILL
LIVN
Price
$43.61
$78.17
Analyst Decision
Buy
Buy
Analyst Count
21
7
Target Price
$57.90
$72.43
AVG Volume (30 Days)
2.4M
622.0K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
74.07
N/A
EPS
0.07
0.40
Revenue
$1,462,570,000.00
N/A
Revenue This Year
$14.18
$9.79
Revenue Next Year
$13.83
$6.63
P/E Ratio
$589.43
$196.53
Revenue Growth
13.36
N/A
52 Week Low
$31.41
$41.02
52 Week High
$57.21
$85.27

Technical Indicators

Market Signals
Indicator
BILL
LIVN
Relative Strength Index (RSI) 60.90 43.69
Support Level $42.06 $61.63
Resistance Level $46.70 $80.96
Average True Range (ATR) 1.86 2.31
MACD -0.01 -0.78
Stochastic Oscillator 67.97 27.67

Price Performance

Historical Comparison
BILL
LIVN

About BILL BILL Holdings Inc.

BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: